Identifying risk factors for patients with asymptomatic Waldenstroms macroglobulinemia

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=MiXuwGtiUkE

Mark Bustoros, MD explains the analysis of asymptomatic Waldenström’s macroglobulinemia patients that helped identify the risk factors that contribute to disease progression. The analysis helped establish a risk-based stratification system based that may help guide clinical care for these patients. The analysis was presented at the 2018 ASH Annual Meeting. For more information on our Center for Prevention of Progression: https://www.dana-farber.org/research/...

#############################

New on site